Global Cord Blood's net profit under GAAP for 6 months of fiscal 2021 was ¥267.747 million, up 15.4% from ¥231.995 million the previous year. Revenue decreased by 3.4% to ¥ 566.52 million compared to ¥ 586.839 million the year before.